Jump to content

Draft:NEXT Life Sciences

From Wikipedia, the free encyclopedia

NEXT Life Sciences

NEXT Life Sciences, Inc. is an American biomedical device company developing a long-acting, reversible male contraceptive device, Plan A for Men[1].

Lead Product: Plan A NEXT’s flagship product is Plan A for Men, which they are designing to be a long-acting, reversible male contraceptive solution.[2] Plan A involves the delivery of a proprietary hydrogel called Vasalgel into the vas deferens, which forms a flexible filter that blocks the flow of sperm.[2]

History

In 2024, NEXT Life Sciences brought on Ryan Breslow, known for building the multi-billion-dollar company Bolt, as a Strategic Advisor.[3] With NEXT, Breslow most led a $2.5M round of funding with participation from Transform VC and a combination of angel investors and early-stage venture funds including entrepreneur Brock Pierce, Transform VC, StartupHealth, Pay It Forward Venture Capital, Particular Ventures, Keno Peer, Unpopular Ventures, and Joy Fund, bringing total seed funding to date to $4M.[3]


References

[edit]
  1. ^ Billups, Erin (2024-07-09). "'New male birth control options are in the works'". Spectrum News 1.
  2. ^ a b Sevigny, Melissa (2024-03-21). "'Male birth control is the 'holy grail' for one Flagstaff company'". KNAU Arizona Public Radio.
  3. ^ a b Torrence, Rebecca (2024-01-16). "'Here's an exclusive look at the 16-slide pitch deck that got Bolt cofounder Ryan Breslow to bet on a male birth control startup'". Business Insider.